Renaissance develops and manufactures high-quality pharmaceuticals
to fulfill specific patient needs.
Renaissance recognizes that patient care relies on quality pharmaceutical drugs that have gained the confidence of healthcare professionals. We are working passionately as a trusted contract manufacturer of pharmaceutical products that you can trust to be time-tested, safe, reliable and proven.
With decades of experience and our state-of-the-art facility in Lakewood, NJ, we can develop and manufacture a broad range of sterile and/or environmentally controlled products. From early-stage development through final production, Renaissance has the expertise and resources you need for success.
THE RENAISSANCE TEAM
Serge Maltais, President & CEO
Serge Maltais serves as President and CEO of Renaissance. With over 30 years of experience in managing operations and leading teams in the pharmaceutical space, he is adept at developing and implementing innovative solutions and achieving results. Previously, Serge served as President and CEO of Héma-Québec, a governmental non-profit organization that manages the supply of blood, human tissues, cord blood, and maternal milk throughout Quebec, Canada. Prior to that, Serge served as VP Supply Chain & Commercial Operations for Sandoz in Canada, and held positions of increasing responsibility within Manufacturing and Operations at Baxter. Serge holds a Bachelor of Industrial Engineering from École Polytechnique in Montréal, as well as a Diploma in Business Administration from Université de Sherbrooke, Sherbrooke.
Robert Harrer, CFO
Brenda Vesey, VP, CHRO
Brenda Vesey serves as the VP – CHRO for Renaissance. She has over 25 years of experience in HR across multiple industries. She has served on a number of Executive Leadership teams and has held a variety of HR leadership roles within the pharmaceutical industry including roles at Teva Pharmaceuticals, Allergan, Actavis, and Alpharma. Prior to that she worked for Toys “R” Us and Chase Manhattan Corporation. While at Chase she worked in both Financial Operations and Human Resources.
Julie Simon, VP, Strategic and Business Development
Julie Simon serves as the VP of Strategic and Business Development for Renaissance. She has over 15 years of management experience in the pharmaceutical industry, with a history of success in identifying & executing unique business opportunities, organizational transformation, and value creation. Julie previously held leadership positions with Ben Venue/Bedford Laboratories, Akorn, APP/Abraxis, Bioniche Pharma and Mylan. Her experience spans commercial, operational and technical verticals, with focus on Business Development, M&A, Commercial Operations, R&D, Strategic Sourcing and Quality.
Kimberly Ernst, VP, Product Development and Regulatory Affairs
Kimberly Ernst serves as the VP of Product Development and Regulatory Affairs. Kim is a seasoned leader with 15 years of experience in the pharmaceutical industry. She has deep experience in preparing regulatory submissions, strategizing effective regulatory pathways, and developing innovative approaches. Before joining Renaissance, Kim worked at Impax Laboratories (via CorePharma acquisition) as the Senior Director, Regulatory Affairs. Prior to Impax she worked in roles of increasing responsibility at Dr. Reddy’s Laboratories, B. Braun Medical Inc, and Teva Pharmaceuticals.
Kim holds a B.S. in Chemistry from Cedar Crest College and an M.S. in Chemistry from Lehigh University.
Dan Brennan, VP of Quality
Eric Kaneps, VP of Sales & Marketing
Eric Kaneps serves as the VP of Sales & Marketing. Eric has over 20 years of experience in Sales, Business Development, and Account Management in the pharmaceutical industry.
Prior to joining Renaissance, Eric led Business Development for Pharma-Tech Industries, a contract manufacturing organization that specializes in prescription and over-the-counter ingestibles and topical products. While there, Eric was responsible for new market expansion through the addition of development services offerings and capability expansion to support drug-device combination products. Prior to Pharma-Tech Industries, Eric worked at DPT Laboratories, Alcan Packaging, and Drug Plastics & Glass Co.
Eric holds a B.S. B.A. in International Business & Economics from The Ohio State University.
James Hamilton, VP of Operations
James Hamilton serves as Vice President of Operations for Renaissance. He has over 25 years of experience in Pharmaceutical Manufacturing and Supply Chain. Most recently, James was VP and Plant General Manager at a large sterile ophthalmic site for Allergan. Prior to that, he was VP of Strategy and Operational Excellence for Actavis. Before joining Actavis, James held various leadership positions of increasing responsibility in Quality, Engineering, and Supply Chain with Forest Laboratories.
James holds a BA in Chemistry from the University of New Mexico and an MBA from Northern Kentucky University.
Al Atkinson, Sr. Director of Commercial Services
Al Atkinson serves as Senior Director of Commercial Services, leading the team responsible for commercial account management. He has over 20 years of leadership experience in Pharmaceutical Manufacturing, Quality Systems, Program Management and Commercial Operations.
Prior to joining Renaissance, Al was Sr. Director of Development Services and Commercial Operations for DPT Laboratories, a Mylan company. In this role, Al had responsibility for the CDMO product development and commercial operations teams as well as oversight of internal tech transfers and repatriation programs for the proprietary business. Prior to this role, Al held positions of increasing responsibility in Manufacturing, Project Management, Quality Systems, Development and Commercial Services.